コンテンツへスキップ
KAICO LTD.

KAICO LTD.

KAICO creates hard-to-express proteins by using specially bred silkworms

  • HOME
    • Press release
  • Core Technology
  • ORAL VACCINE
  • COVID19抗体測定サービス
  • Recruit

papers

関連論文

Reference Papers




KAICO members’ and our technical advisors’ papers

High yield production of norovirus GII.4 virus-like particles using silkworm pupae and evaluation of their protective immunogenicity

Active Human and Murine Tumor Necrosis Factor α Cytokines Produced from Silkworm Baculovirus Expression System. Insects

Stable trimer formation of spike protein from porcine epidemic diarrhea virus improves the efficiency of secretory production in silkworms and induces neutralizing antibodies in mice.

Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation With Alum Adjuvants

Production of scFv, Fab, and IgG of CR3022 Antibodies Against SARS- CoV-2 Using Silkworm-Baculovirus Expression System. Mol. Biotechnol

Production of an active Mus musculus IL-3 using updated silkworm-based baculovirus expression vector system. J. Asia-Pacific Entomol.

Efficient production of recombinant SARS-CoV-2 spike protein using the baculovirus-silkworm system. Biochem.Biophys. Res. Commun.

Heme precursor injection is effective for Arthromyces ramosus peroxidase fusion protein production by a silkworm expression system

Expression and activation of horseradish peroxidase-protein A/G fusion protein in silkworm larvae for diagnostic purpose.

Contact Information :

KAICO株式会社
〒819-0388 福岡市西区九大新町4−1
tel 092(707)4016   fax 092(707)4017

e-mail: info-kaico@kaicoltd.jp

KAICO LTD.
4-1, Kyudaishin-machi, Nishi-ku, Fukuoka City
tel+81 92 707 4016 fax +81 92 707 4017

Proudly powered by WordPress